vs
AIRGAIN INC(AIRG)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是AIRGAIN INC的1.6倍($19.6M vs $12.1M),AIRGAIN INC净利率更高(-20.1% vs -177.4%,领先157.3%),STANDARD BIOTOOLS INC.同比增速更快(-11.5% vs -19.6%),AIRGAIN INC自由现金流更多($93.0K vs $-23.1M),过去两年AIRGAIN INC的营收复合增速更高(-7.7% vs -12.2%)
Airgain Inc是一家专业无线连接解决方案提供商,主要生产高性能天线、嵌入式无线模块及定制化连接系统,服务覆盖物联网、汽车电子、智能家居、企业网络及电信等核心领域,为各类联网设备提供稳定高速的无线连接支持。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
AIRG vs LAB — 直观对比
营收规模更大
LAB
是对方的1.6倍
$12.1M
营收增速更快
LAB
高出8.1%
-19.6%
净利率更高
AIRG
高出157.3%
-177.4%
自由现金流更多
AIRG
多$23.2M
$-23.1M
两年增速更快
AIRG
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $12.1M | $19.6M |
| 净利润 | $-2.4M | $-34.7M |
| 毛利率 | 44.8% | 48.5% |
| 营业利润率 | -20.0% | -168.5% |
| 净利率 | -20.1% | -177.4% |
| 营收同比 | -19.6% | -11.5% |
| 净利润同比 | -24.4% | -28.8% |
| 每股收益(稀释后) | $-0.21 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AIRG
LAB
| Q4 25 | $12.1M | — | ||
| Q3 25 | $14.0M | $19.6M | ||
| Q2 25 | $13.6M | $21.8M | ||
| Q1 25 | $12.0M | $40.8M | ||
| Q4 24 | $15.1M | — | ||
| Q3 24 | $16.1M | $22.1M | ||
| Q2 24 | $15.2M | $22.5M | ||
| Q1 24 | $14.2M | $45.5M |
净利润
AIRG
LAB
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-964.0K | $-34.7M | ||
| Q2 25 | $-1.5M | $-33.5M | ||
| Q1 25 | $-1.5M | $-26.0M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-1.8M | $-26.9M | ||
| Q2 24 | $-2.5M | $-45.7M | ||
| Q1 24 | $-2.5M | $-32.2M |
毛利率
AIRG
LAB
| Q4 25 | 44.8% | — | ||
| Q3 25 | 43.6% | 48.5% | ||
| Q2 25 | 42.9% | 48.8% | ||
| Q1 25 | 43.0% | 48.4% | ||
| Q4 24 | 42.2% | — | ||
| Q3 24 | 41.7% | 54.9% | ||
| Q2 24 | 40.5% | 46.1% | ||
| Q1 24 | 39.2% | 53.1% |
营业利润率
AIRG
LAB
| Q4 25 | -20.0% | — | ||
| Q3 25 | -6.9% | -168.5% | ||
| Q2 25 | -14.7% | -118.1% | ||
| Q1 25 | -25.8% | -80.8% | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | -11.3% | -120.9% | ||
| Q2 24 | -16.5% | -134.5% | ||
| Q1 24 | -18.5% | -132.2% |
净利率
AIRG
LAB
| Q4 25 | -20.1% | — | ||
| Q3 25 | -6.9% | -177.4% | ||
| Q2 25 | -10.8% | -153.7% | ||
| Q1 25 | -12.9% | -63.8% | ||
| Q4 24 | -13.0% | — | ||
| Q3 24 | -10.9% | -122.0% | ||
| Q2 24 | -16.6% | -203.3% | ||
| Q1 24 | -17.3% | -70.6% |
每股收益(稀释后)
AIRG
LAB
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.08 | $-0.09 | ||
| Q2 25 | $-0.12 | $-0.09 | ||
| Q1 25 | $-0.13 | $-0.07 | ||
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.16 | $-0.07 | ||
| Q2 24 | $-0.23 | $-0.12 | ||
| Q1 24 | $-0.23 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $7.4M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $28.3M | $399.7M |
| 总资产 | $45.3M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AIRG
LAB
| Q4 25 | $7.4M | — | ||
| Q3 25 | $7.1M | $129.4M | ||
| Q2 25 | $7.7M | $158.6M | ||
| Q1 25 | $7.4M | $150.9M | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $7.3M | $210.6M | ||
| Q2 24 | $8.4M | $269.8M | ||
| Q1 24 | $7.2M | $287.1M |
总债务
AIRG
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
AIRG
LAB
| Q4 25 | $28.3M | — | ||
| Q3 25 | $29.7M | $399.7M | ||
| Q2 25 | $29.8M | $424.5M | ||
| Q1 25 | $30.3M | $454.6M | ||
| Q4 24 | $31.0M | — | ||
| Q3 24 | $30.8M | $489.3M | ||
| Q2 24 | $31.6M | $510.3M | ||
| Q1 24 | $30.5M | $577.3M |
总资产
AIRG
LAB
| Q4 25 | $45.3M | — | ||
| Q3 25 | $45.5M | $539.6M | ||
| Q2 25 | $45.5M | $557.0M | ||
| Q1 25 | $46.1M | $579.6M | ||
| Q4 24 | $48.4M | — | ||
| Q3 24 | $43.3M | $681.5M | ||
| Q2 24 | $42.4M | $708.7M | ||
| Q1 24 | $42.8M | $777.7M |
负债/权益比
AIRG
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $194.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $93.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | 0.8% | -118.1% |
| 资本支出强度资本支出/营收 | 0.8% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
AIRG
LAB
| Q4 25 | $194.0K | — | ||
| Q3 25 | $-411.0K | $-22.2M | ||
| Q2 25 | $129.0K | $-20.7M | ||
| Q1 25 | $-1.0M | $-30.3M | ||
| Q4 24 | $-26.0K | — | ||
| Q3 24 | $-1.2M | $-27.9M | ||
| Q2 24 | $-1.2M | $-39.0M | ||
| Q1 24 | $-1.1M | $-62.5M |
自由现金流
AIRG
LAB
| Q4 25 | $93.0K | — | ||
| Q3 25 | $-418.0K | $-23.1M | ||
| Q2 25 | $113.0K | $-22.6M | ||
| Q1 25 | $-1.1M | $-35.3M | ||
| Q4 24 | $-27.0K | — | ||
| Q3 24 | $-1.2M | $-30.1M | ||
| Q2 24 | $-1.3M | $-41.0M | ||
| Q1 24 | $-1.2M | $-63.3M |
自由现金流率
AIRG
LAB
| Q4 25 | 0.8% | — | ||
| Q3 25 | -3.0% | -118.1% | ||
| Q2 25 | 0.8% | -103.6% | ||
| Q1 25 | -8.9% | -86.6% | ||
| Q4 24 | -0.2% | — | ||
| Q3 24 | -7.5% | -136.4% | ||
| Q2 24 | -8.5% | -182.2% | ||
| Q1 24 | -8.3% | -138.9% |
资本支出强度
AIRG
LAB
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 0.1% | 8.7% | ||
| Q1 25 | 0.3% | 12.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | 10.2% | ||
| Q2 24 | 0.6% | 8.6% | ||
| Q1 24 | 0.4% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIRG
| Transferred At Point In Time | $11.3M | 93% |
| Other | $803.0K | 7% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |